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1. Introduction
1.1. Aphrodisiac 
   Aphrodisiac is the word derived from Aphrodite, the 
Greek goddess of sexual, love and beauty. An aphrodisiac 
is defined as an agent (food or drug) that arouses sexual 
desire. From time immemorial man’s endeavour have been 
to increase his sexual powers. When man did not know 
metals and used only stones he exhibited his sexual powers 
by ritual dances accompanied by hunting. This lead early 
man was motivated by his quest for food, sex and self-
preservation. The possibility of bioactive aphrodisiacs 
which may be derived from plants, animals or minerals, has 
been attractive throughout recorded history. Aphrodisiac 
are mentioned there as Vajikaranas, the word vaji meaning 
horse and karanta meaning making i.e. Measure to excite 
lust by charms etc[1-3].
   Erectile dysfunction, sometimes, which also may imply 
to refer to “impotence,” is the repeated inability to get or 
keep an erection firm enough for sexual intercourse.  The 
causes of ED are varies from one individual to another. 
For whatever cause, since an erection requires a precise 
sequence of events, ED can occur when any of the events 
is disrupted. This sequence includes nerve impulses in 
the brain, spinal column, and area around the penis, and 
response in muscles, fibrous tissues, veins, and arteries in 
and near the corpora cavernosa. Thus, ED causes reported 
include, damage to nerves, arteries, smooth muscles, and 
fibrous tissues. These are often as a result of diseases, such 
as diabetes, kidney disease, chronic alcoholism, multiple 
sclerosis, atherosclerosis, vascular disease, and neurologic 
diseases that account for about 70 percent of ED cases. 
NIH reported that between 35 and 50 percent of men with 
diabetes experience ED. NIH further reported that the usage 
of many common medicines such as blood pressure drugs, 
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antihistamines, antidepressants, tranquilizers, appetite 
suppressants, and cimetidine (an ulcer drug) can produce 
ED as a side effect. Nevertheless, psychological factors such 
as stress, anxiety, guilt, depression, low self-esteem, and 
fear of sexual failure cause 10 to 20 percent of ED cases. 
In addition, men with a physical cause for ED frequently 
experience the same sort of psychological reactions (stress, 
anxiety, guilt, and depression). Other possible causes are 
smoking, which affects blood flow in veins and arteries, and 
hormonal abnormalities, such as not enough testosterone. 
In modern medication of erectile dysfunction, the oral 
prescription medication of popular Viagra (Sildenafil) is 
effective, but in some men it is not compatible and Sildenafil 
works in less than 70% of men with various etiologies 
and has certain side effects[4]. The availability of Viagra 
has brought millions of couples to ED treatment. Oral 
testosterone can reduce ED in some men with low levels of 
natural testosterone, but it is often ineffective and may cause 
liver damage[7]. Other drugs such as Yohimbine, papaverine 
hydrochloride used under careful medical supervision, 
phentolamine, and alprostadil (marketed as Caverject) widen 
blood vessels[5]. 
   Penile erection is a hemodynamic event in the penis. 
It is the end result of relaxation of the cavernous tissue 
that involves both the central nervous system and the 
local factors[5]. The basic concepts of penile erection were 
obtained from in vivo and in vitro animals models. The 
present review is an attempt to update the information on 
the aphrodisiac animal’s models.
1.2 Guidelines follow during experiment
The following guidelines followed during experiment:
• Males were kept individually but females were kept in 
groups.
• Training of each male for 15 min at a time was performed 
until sexual behavior was elicited and when the behavior 
was noticed, males were exposed to receptive females (1 
male with 5 females);
• Repeated training to overcome the lack of sexual response 
in the presence of observers;
• The study was conducted in a silent room under dim red 
light;
• Any jerking movement of the mating area was avoided to 
enable the rats to chase each other;
• Cleaning of the mating area was performed after each trial, 
since the urine trails left by one rat might alter the sexual 
behavior of the next rat[3].
1.3. Evaluation of aphrodisiac agents
   The therapeutic value, efficacy and toxicity of drug may 
be evaluated in animals experimentally, followed by clinical 
trials. Both in-vivo and in-vitro animal models are employed 
to assess aphrodisiac activity in experimental animals (rat, 
mice & guinea pig etc.) 
2. Parameters used in assessing aphrodisiac activity
   For the study of aphrodisiac activity many in-vitro and in-
vivo models have been used.
2.1. Physical methods: mating behavior test
   The mating behavior tests would be carried out by the 
methods of Kolodny & Govier et al., and modified by 
Walsh et al[7-9]. Briefly, healthy and sexually experienced 
male albino rats that show brisk sexual activity should be 
selected for the study. After extract administration at various 
concentration to various groups of the animals depending 
on the experimental design and objective(s) of the study, 
the male animals should be brought to the laboratory 
and exposed to red dim light (in 1 w fluorescent tube in a 
laboratory of 14’ × 14’) at the stipulated time of testing daily 
for some days (3-6 d) before the experiment. 
   The female animals should be artificially brought 
into oestrus phase (heat) as the female rats allow mating 
only during the oestrus phase by administering either 
suspension of ethinyl oestradiol orally at the dose of 100 
毺g/animal 48 h prior to the pairing and subcutaneous 
administration of progesterone at the dose of 1 mg/animal 6 
h before the experiment or alternatively by the sequential 
administration of estradiol benzoate (10 毺g/100 g body 
weight) and progesterone (0.5 mg/100 g body weight) through 
subcutaneous injections, 48 h and 4 h respectively prior 
to pairing. The receptivity of the female animals should 
be confirmed before the test by exposing them to male 
animals, other than the control and test animals. The most 
receptive females should then be selected for the study. 
The experiment should be conducted at 20:00 h in the same 
laboratory and under light of same intensity. The receptive 
female animals should be introduced into the cages of male 
animals in the ratio 1 female to 1 male. The observation 
for mating behaviour should commence immediately and 
continued for first 2 mating series. The test should be 
terminated if the male failed to evince sexual interest. 
Any female animal that do not show receptivity should 
be replaced by another artificially ‘warmed’ female. The 
occurrence of events and phases of mating may be called out 
to be recorded on audio-cassette as soon as they appeared. 
Their disappearance should also be called out and recorded. 
Later, the frequencies and phases should be determined 
from cassette transcriptions. The parameters of male sexual 
behavior that should be monitored should include:
I. Mount frequency
   Mounting is defined as the climbing of one animal by 
another usually from the posterior end with the intention 
of introducing one organ into another. Mount may also be 
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operationally defined as the male assuming the copulatory 
position but failing to achieve intromission. Mount 
Frequency (MF) is therefore defined as the number of mounts 
without intromission from the time of introduction of the 
female until ejaculation.
II. Intromission frequency
  Intromission is the introduction of one organ or parts 
into another. e.g. the penis into the vagina. Intromission 
Frequency (IF) is therefore defined as the number of 
intromissions from the time of introduction of the female 
until ejaculation.
III. Mount latency
   Mount latency (ML) is defined as the time interval between 
the introduction of the female and the first mount by the 
male.
IV. Intromission latency
   Intromission latency (IL) is the time interval from the time 
of introduction of the female to the first intromission by the 
male. This is usually characterized by pelvic thrusting, and 
springing dismounts.
V. Ejaculatory latency
   Ejaculation is the act of ejecting semen brought about by a 
reflex action that occurs as the result of sexual stimulation. 
Ejaculatory latency (EL) is defined as the time interval 
between the first intromission and ejaculation. This is 
usually characterized by longer, deeper pelvic thrusting and 
slow dismount followed by a period of inactivity or reduced 
activity.
VI. Post-ejaculatory interval
   Post-ejaculatory interval (PEI) is the time interval between 
ejaculation and the first intromission of the following 
series[11].
VII. Copulatory rate 
   Copulatory rate was calculated by determining the number 
of mounts plus number of intromissions divided by the time 
from the first mount until ejaculation.
Copulatory rate: 
Number of mounts + Number of intromissions
Time from first mount till ejaculation
        
VIII. Index of libido
   Index of Libido is defined as the ratio of number mated 
to number paired expressed in percentage. This can be 
expressed mathematically as:
% index of libido = 
Number mated 
Number paired
 
× 100
                  
IX. Computed male sexual behaviour parameters
   Using the above parameters of sexual behaviour, the 
following can thus be computed:
 The parameters can be counted as:
a) % Mounted =    Number mounted 
     Number paired × 100
                 b) % Intromitted = Number of intromissions  × 100
        Number paired
                                  c) Intromission ratio =  
Number of Intromission
Number of mounts + Number of intromissions
× 100
d) % Ejaculated =
    Number of ejaculations
Number paired × 100
e) Copulatory efficiency = 
Number of intromissions 
Number of mounts
 × 100
f) Intercopulatory efficiency = Average time between 
intromissions[10,11].
   Any medicinal plant with aphrodisiac potential should 
produce statistically significant increase in the indices 
of sexual vigor of mount and intromission frequencies, 
significant decrease in mount and intromission latencies. 
These indices are indicators of stimulation of sexual 
arousability, motivation and vigour[12,13]. The significant 
decrease in mount and intromission latencies as well as 
significant increase in computed male sexual behavior 
parameters of %mounted, % intromitted, %ejaculated and 
the reduction in intercopulatory efficiency are indications 
of sustained increase in sexual activity and aphrodisiac 
property inherent in the plant extract[11].
2.2. Test for libido 
   Sexually experienced male albino rats should be kept 
singly in separate cages during the experiment. The female 
rats should be made receptive by hormonal treatment and all 
the animals should be accustomed to the testing condition 
as previously presented in mating behavior test. The animals 
should be observed for the mounting frequency (MF) on 
the evening of specific day according to the design of the 
experiment (likely 7th day) at 20:00 h. The penis should be 
exposed by retracting the sheath and apply 5% xylocaine 
ointment 30, 15 and 5 min before starting observations. 
Each animal should be placed individually in a cage with 
the receptive female rat in the same cage. The number of 
mountings should be noted. The animals should also be 
observed for intromission and ejaculation[9,14].
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2.3. Test for potency 
   The male animals are kept singly. The Extracts are 
administered before half or one hour of the experiment. 
On the 8th day test for penile reflexes would be carried 
out by putting the animal on its back in a glass cylinder 
with partial restrain. The perpetual sheath would be 
pushed behind the glans for 15 min to stimulate genital 
reflexes. Total penile reflexes are obtained as sum of 
erections, quick flips and long flips.
   From the above listed components of penile erection, 
the Total Penile Reflexes (TPR) which is the sum total of 
each of the components of penile erection i.e. E + QF + 
LF is obtained. Statistically significant increase in the 
frequency of penile reflexes suggests a medicinal plant 
with aphrodisiac potential[9,15,16].
2.4. Penile microcirculation study
   Laser doppler flow meter may used for determine 
penile microcirculations. Intravenous anaesthesia of 
pentoborbitol sodium would given (dose 30 mg/kg body 
weight). Penile sheath would retracted manually, after 10 
min of adaptation the Laser Doppler Flow detection probe 
would be positioned in a holder close (2-3 mm) to the 
dorsal side of penis. Average flow units (flux) within 10 
min of the test would be calculated.
2.5. Intracavernous pressure (ICP) study
   After 12 h of plant extracts administration animals 
would be given intraperitoneal anaesthesia of sodium 
pentobarbital (50 mg/kg body weight). This should be 
followed by the incision of the penile skin and degloving 
of the prepuce to expose the corpora cavernosa. A 26 
gauge needle connected to a polyethylene tube (PE-50) 
filled with NSS with 100 IU/mL of heparin on one side of 
the Corpora cavernosa is inserted for ICP measurement. 
Another 22 gauge needle is placed into the right carotid 
artery connected to a PE-tube for the measurement 
of mean arterial pressure (MAP). Both tubes should be 
connected to blood pressure transducers which should 
also be connected to a data acquisition board via 
transducer amplifiers. Computers can be used to see real 
time display and recording of pressure measurements 
(mmHg). Similarly, the major pelvic ganglion, pelvic and 
cavernous nerves can be exposed by a midline abdominal 
incision. The cavernous nerve can then be stimulated by 
using a square pulse stimulator connected to a platinum 
bipolar electrode positioned on the cavernous nerve using 
five volts with a frequency of 50 Hertz and duration of 5 
min as stimulus parameters. The stimulation may be done 
three times and the ICP can then be recorded. The ICP 
should be allowed to return to baseline before the next 
stimulation.   Statistically significant increase in ICP may 
imply their role on nitric oxide (NO) and erectile function. 
Medicinal plants with aphrodisiac potential should be 
capable of stimulating cavernous nerve which normally 
should lead to increase in NO and cyclic Guanosine 
Phosphate (cGMP) signalling in corpus cavernosal smooth 
muscle relaxation. The subsequent arteriolar dilation 
leading to increased arterial inflow and impaired venous 
return (due to engorgement of the cavernosum) builds up 
a pressure system within the corpora that result in penile 
tumescence and rigidity[17].
2.6. Orientation behavior
   Effects of extract of medicinal plant on behavior of 
male rats was  gauged by evaluation of three different 
parameters viz., (1) behavior towards female which 
involved licking and sniffing of female anogential organ, 
(2) self exploratory behavior which included non-gential 
grooming and gential grooming, and (3) general behavior 
which comprised of exploration, rearing and climbing. 
The behavior of rats was digitally recorded by using 
camera. The number of episodes of each of the behavior 
parameters would be counted. Scoring is based on the 
episodes performed by the rats and every episode has 
certain points. The observations would be made daily and 
scores on day 0 (just before extract administration), and 
subsequent days of experimentation.
   The scoring was made giving a value of 0 (no sexual 
activity), 1 (no interaction, rears and climbs on chamber), 
2 (sniffs other rat), 3 self- exploratory behavior i.e., 
grooming and sniffing of gentials, 4 (grooms female rat 
anywhere), 5 (rears and climbs sexually), 6 (pursues and 
sniffs other rat), 7 (tries to mount but easily discouraged), 
8 ( Mounts with an integrated deliberate manner, not 
easily discouraged), 9 ( reflex and almost involuntary 
mount)[18,19].
2.7. Determination of hesitation time & attraction towards 
female
   A female rat was placed in a cage which had a 
wooden barrier of 15 cm separating male and female 
compartments which could be passed by a motivated 
male rat. The hesitation time was recorded as the time (in 
sec) required by the male rat before making an attempt to 
cross the barrier. In the same way, a scoring for attraction 
towards female was recorded by a score between 0-5 
during an observation period of 15 min. A complete cross 
of the partition by the male rat each time was given a 
score of 5 while an attempt to climb was given a score of 
2 and disinterest to climb was rated as 0. The readings 
were recorded on Days 0, 7, 14, 21, and 28 of treatment. 
This test is useful in determining the willingness of a 
male rat to cross an aversive or obstructive position, 
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thus indicating the intent of sexual attraction. Male rats 
of all the groups were subjected to experimentation and 
their scores for attraction as well as hesitation time were 
recorded[18,19].
2.8. Pendiculation study
   Pendiculations (act of yawing and stretching) were 
studied following the method of Baggio and Ferrari. 
The study was performed during the dark phase of the 
light-dark cycle (20:00-07:00 h) and in subdued red 
light. Treated male rats were given respective dose of 
test drugs while controls received water only. The rats 
were then placed individually in a wooden observation 
chamber with a glass and remained undisturbed during 
observation period. Yawing and stretching were counted 
from video recorded observation and not more than 
one rat was observed simultaneously. The occurrence 
of Pendiculations was recorded for animals responding 
during a 1h observation period. Each rat was used only 
once. The Pendiculations were recorded on day 0 and day 
14 of treatment[20].
2.9. Biochemical studies
2.9.1. Determination of testicular and serum cholesterol 
(Chod PAP method)
   Cholesterol is the precursor in the synthesis of many 
physiologically important steroids such as bile acids, 
steroid hormones and vitamin D and its requirement 
for normal testicular activity has been well established.
Testicular and serum cholesterol concentrations may be 
determined by the Chod-PAP method as Briefly, 0.02 
cm3 of the sample is mixed with 2.00 cm3 of the working 
reagent and the absorbance of the resulting mixture is 
read after five minutes at 546 nm.
   A medicinal plant with potential for aphrodisiac should 
result in statistically significant increase in testicular and 
or serum cholesterol concentration. Such increase may 
imply stimulation in the steroid genesis, which may lead 
to increased testosterone concentration. Such increase 
in testosterone concentration should normally reflect a 
corresponding increase in libido[21-23].
2.9.2. Hormonal determination assay
   The positive effects on the indices of male sexual 
behavior must have been brought about by the 
constituents of the medicinal plant on some reproductive 
hormones. These include testosterone, luteinizing 
hormone (LH), follicle stimulating hormone (FSH) and 
prolactin. Therefore, there is the need to evaluate 
the effect of administration of the extract of the plant 
associated with aphrodisiac potentials on the serum 
concentrations of these hormones. Testosterone 
supplementation has previously been shown to improve 
sexual function and libido, in addition to the intensity 
of orgasm and ejaculation which is likely to improve. 
Testosterone in the blood exists in three different forms 
namely: free, albumin-bound and sex-hormone binding 
globulin (SHBG). While it is generally considered that 
SHBG bound testosterone is not available for uptake by 
tissues, opinion is mixed as to whether the biologically 
active testosterone is restricted to the small quantity 
of the hormone that is free (2%) or includes the larger 
amount of albumin bound hormone (20%-80%). However, 
investigations suggest that both free and albumin-
bound testosterone is biologically available. Generally, 
elevated testosterone level also enhances the sexual 
behavior in humans. Therefore, an increase in testicular 
and serum free testosterone concentration will confirm 
aphrodisiac potential inherent in the plant extract. 
Luteinizing hormones (LH) and Follicle Stimulating 
Hormone (FSH) produced by anterior pituitary lobe are 
necessary for maintaining testosterone levels such that as 
LH and FSH increases so do the testosterone. Therefore, a 
medicinal plant acclaimed to have aphrodisiac potential 
apart from being able to increase the concentration of 
bioavailable/free testosterone should cause increase in 
the concentrations of serum LH and FSH. An increase 
in the concentrations of LH and FSH should normally 
increase the testosterone concentration. Normally, 
prolactin is made by specialized pituitary cells called 
lactotrophs. Prolactin increases the production of breast 
milk and suppresses secretion of LH and FSH. The role 
of prolactin in men is not known. However, high levels 
of prolactin in men may cause hypogonadism, low blood 
testosterone levels and decrease in sex drive (libido) 
and sexual function. Therefore, any plant associated 
with aphrodisiac tendency should produce statistically 
significant reduction in the concentrations of prolactin in 
males which would enhance the levels of LH and FSH and 
by extension the testosterone concentration[24-26].
2.10. Assay for neuronic nitric oxide synthase (NOS) and 
androgen receptor protein
   Activity of NOS can be estimated by use of western 
method. Nitric Oxide Synthase (NOS), a calcium/
calmodulin dependent enzyme is responsible for the 
biosynthesis of nitric oxide (NO) from L-arginine. Since 
nitric oxide is responsible for the relaxation of smooth 
muscles of the cavernosum which eventually lead to 
in-flow of blood into the male organ, determination of 
the activity of NOS in the male copulatory organ and 
the testes is very imperative as this will lend credence 
to results that will be obtained from the ICP study. The 
activity of NOS can be estimated by the use of Western 
Blot. Similarly, analysis of Androgen Receptor (AR) 
protein will further give an idea of the receptors available 
for the binding of the androgens notably the free or 
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bioavailable testosterone[27].
2.11. In- vitro nitric oxide release
   DS-1 cells (human corpus cavernosum cell line) were 
routinely cultured in a humidified 5% CO2-95% air 
incubator in Dulbecco’s modified eagles medium (DMEM) 
supplemented with 10% fetal bovine serum (FBS), 20 µM 
L-glutamine, 1 mM pyruvate, 200 U/mL penicillin G, 
200 毺g/mL streptomycin and 4.5 mg/mL of D-glucose 
at 37 曟. Cells were allowed to attach to the bottom of a 
96-well plate overnight and were then exposed to the 
extract (10 mg/mL PBS) or placebo PBS (control) for 24 
h. The cell media was assayed for the concentrations of 
nitrate (NO3
-
) and nitrite (NO2
-
), the final in-vivo products 
of NO, using a commercial nitrate reductase preparation 
and Griess reagent kit (Cayman Chemical, USA) with the 
resultant absorbance being read at 550 nm using a plate 
reader[28].
2.12. Effect on sexual organ weight and histological 
studies
   After 28 d of treatment, the body weights of animals 
were taken, after which all animals were killed by 
decapitation. Testis, seminal vesicles, epididymis and 
prostate glands were carefully removed and weighed. 
Testis of animals were cut into small pieces, fixed 
in Bovine’s fixative and dehydrated with varying 
percentages of ethanol for histological studies. Sections 
were cut (6 m), stained with haemotoxylin and eosin and 
then analysed microscopically[29]. 
2.13. In vitro sperm preservation
   The epididymides of the rats were taken into 5 mL of 
1% sodium citrate solution and squashed thoroughly with 
the help of needle and forceps until a milky suspension 
was obtained. The solution was filtered through 80 m 
mesh and the volume was made up to 10 mL, inclusive of 
washings of the filter. A 1 mg/mL solution of extracts of 
A. longifolia (1 mg/mL) was prepared and added into the 
sperm specimens in the test sample in a ratio of 0.1:1 (100 
毺L sperm solution: 1 mL extract solution). The sperms 
were counted at 0 and 30 min after incubation at room 
temperature. The spermatozoa were counted in a five 
WBC counting chamber. The average number of sperm 
per chamber was reported[29].
2.14. In-vivo sperm count
   In-vivo sperm count. Epididymis of rats of each group 
were homogenized and taken into 5 mL of 1% sodium 
citrate solution and squashed thoroughly with the help 
of needle and forceps until a milky suspension was 
obtained. The solution was filtered through 80 m mesh 
and the volume was made up to 10 mL with the same 
solution; the made up volume was inclusive of washings 
of the filter. The suspension was shaken thoroughly and 
the spermatozoa were counted in five WBC counting 
chambers of the haemocytometer. The average numbers 
of sperms per chamber are reported. The progressive 
sperm motility, spermcount, live/dead ratio (viability) and 
morphology were determined[30].
2.14.1. Fructose content in seminal vesicles
   The seminal vesicles were macerated with 3 mL of 
distilled water and centrifuged at 4 000 r.p.m. for 12 min. 
To the supernatant, fluid collected after centrifugation 
add 0.5 mL of resoreinol and 1.5 mL of HCl. The mixture 
was kept at 80 曟 for 12 min. The reaction with resorcinol 
developed a rosy colour, which was measured at 500 nm 
using spectrophotometer. A calibration curve was drawn 
using dilutions of fructose solution and measument of the 
colour developed with resorcinol and HCl[30].
3. Conclusion
   Drug discovery and development consists of a 
series of processes starting with the demonstration of 
pharmacological effects in experimental animal models 
and cell lines and ending with drug safety and efficacy 
studies in patients. The main limitation is often the 
unacceptable level of toxicity with herbal drug. The 
study of aphrodisiac agents has been an important field 
of research. The article explains various types of animal 
models which are employed in the study of aphrodisiac 
agents. 
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